Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) has received a consensus rating of “Hold” from the six analysts that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $1.67.
Several analysts have issued reports on CVRS shares. Zacks Investment Research raised shares of Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.25 price objective for the company in a research note on Tuesday, July 10th. Stifel Nicolaus downgraded shares of Corindus Vascular Robotics from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $3.00 to $1.00 in a research note on Wednesday, August 8th.
In related news, Director Louis A. Cannon purchased 31,000 shares of the firm’s stock in a transaction dated Monday, August 13th. The stock was purchased at an average price of $0.96 per share, with a total value of $29,760.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Louis A. Cannon purchased 30,000 shares of the firm’s stock in a transaction dated Wednesday, August 22nd. The shares were bought at an average cost of $0.99 per share, with a total value of $29,700.00. The disclosure for this purchase can be found here. In the last three months, insiders acquired 91,000 shares of company stock valued at $90,060.
Institutional investors have recently bought and sold shares of the company. The Manufacturers Life Insurance Company raised its stake in shares of Corindus Vascular Robotics by 245.0% during the first quarter. The Manufacturers Life Insurance Company now owns 89,025 shares of the medical equipment provider’s stock valued at $122,000 after acquiring an additional 63,217 shares in the last quarter. Jane Street Group LLC raised its stake in shares of Corindus Vascular Robotics by 1,328.2% during the second quarter. Jane Street Group LLC now owns 232,855 shares of the medical equipment provider’s stock valued at $192,000 after acquiring an additional 216,551 shares in the last quarter. LMR Partners LLP bought a new stake in shares of Corindus Vascular Robotics during the second quarter valued at approximately $218,000. Paloma Partners Management Co bought a new stake in shares of Corindus Vascular Robotics during the second quarter valued at approximately $409,000. Finally, Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Corindus Vascular Robotics by 164.9% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 569,466 shares of the medical equipment provider’s stock valued at $470,000 after acquiring an additional 354,486 shares in the last quarter.
Shares of NYSEAMERICAN:CVRS opened at $1.35 on Thursday. Corindus Vascular Robotics has a 12 month low of $0.66 and a 12 month high of $1.65.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its quarterly earnings results on Tuesday, August 7th. The medical equipment provider reported ($0.06) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.01). Corindus Vascular Robotics had a negative net margin of 323.84% and a negative return on equity of 110.93%. The business had revenue of $1.67 million during the quarter, compared to the consensus estimate of $3.00 million.
Corindus Vascular Robotics Company Profile
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.
Featured Story: Outstanding Shares
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.